S Windecker

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study
    Peter Wenaweser
    Department of Cardiology, University of Bern, Bern, Switzerland
    J Am Coll Cardiol 52:1134-40. 2008
  2. ncbi request reprint Transcatheter aortic valve implantation: patient selection
    S Stortecky
    Department of Cardiology Swiss Cardiovascular Center Bern University Hospital, Bern, Switzerland
    Minerva Cardioangiol 61:487-97. 2013
  3. doi request reprint Future treatment strategies in ST-segment elevation myocardial infarction
    Stephan Windecker
    Department of Cardiology, Bern University Hospital, Bern, Switzerland
    Lancet 382:644-57. 2013
  4. doi request reprint Transcatheter aortic valve implantation: prevention and management of complications
    Stefan Stortecky
    Department of Cardiology, Swiss Cardiovascular Centre Bern, University Hospital, Bern, Switzerland
    Heart 98:iv52-64. 2012
  5. doi request reprint Transcatheter aortic valve implantation: the procedure
    Stefan Stortecky
    Department of Cardiology, Swiss Cardiovascular Centre Bern, Bern University Hospital, Bern, Switzerland
    Heart 98:iv44-51. 2012
  6. doi request reprint Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study
    Lorenz Räber
    Department of Cardiology, Bern University Hospital, Bern, Switzerland
    Circulation 125:1110-21. 2012
  7. pmc Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design
    Ahmed A Khattab
    Cardiology Department, Bern University Hospital, Bern, Switzerland
    Trials 12:56. 2011
  8. doi request reprint Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    Stephan Windecker
    Department of Cardiology, and CTU Bern, Bern University Hospital, Bern, Switzerland
    Lancet 372:1163-73. 2008
  9. ncbi request reprint Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock
    Stephan Windecker
    Department of Cardiology, University Hospital Bern, Switzerland
    Curr Opin Crit Care 13:521-7. 2007
  10. ncbi request reprint [Cryptogenic stroke and patent foramen ovale]
    S Windecker
    Inselspital Bern, Universitatsspital, Bern
    Ther Umsch 60:553-61. 2003

Detail Information

Publications94

  1. doi request reprint Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study
    Peter Wenaweser
    Department of Cardiology, University of Bern, Bern, Switzerland
    J Am Coll Cardiol 52:1134-40. 2008
    ..We sought to determine the risk of late stent thrombosis (ST) during long-term follow-up beyond 3 years, searched for predictors, and assessed the impact of ST on overall mortality...
  2. ncbi request reprint Transcatheter aortic valve implantation: patient selection
    S Stortecky
    Department of Cardiology Swiss Cardiovascular Center Bern University Hospital, Bern, Switzerland
    Minerva Cardioangiol 61:487-97. 2013
    ..This review will familiarize the reader with the concepts of the interdisciplinary Heart team, risk scores as well as the most important imaging algorithms suited to select appropriate TAVI patients. ..
  3. doi request reprint Future treatment strategies in ST-segment elevation myocardial infarction
    Stephan Windecker
    Department of Cardiology, Bern University Hospital, Bern, Switzerland
    Lancet 382:644-57. 2013
    ..Translational efforts to improve patients' outcomes after STEMI in relation to cardioprotection, cardiac remodelling, and regeneration are also being realised. ..
  4. doi request reprint Transcatheter aortic valve implantation: prevention and management of complications
    Stefan Stortecky
    Department of Cardiology, Swiss Cardiovascular Centre Bern, University Hospital, Bern, Switzerland
    Heart 98:iv52-64. 2012
    ....
  5. doi request reprint Transcatheter aortic valve implantation: the procedure
    Stefan Stortecky
    Department of Cardiology, Swiss Cardiovascular Centre Bern, Bern University Hospital, Bern, Switzerland
    Heart 98:iv44-51. 2012
    ..This article will focus on the different access site options available to operators, provide a step-by-step guide through the procedure, and a detailed description of the technological evolution of transcatheter heart valve systems...
  6. doi request reprint Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study
    Lorenz Räber
    Department of Cardiology, Bern University Hospital, Bern, Switzerland
    Circulation 125:1110-21. 2012
    ..It is unknown whether the risk of very late stent thrombosis persists with newer-generation everolimus-eluting stents (EES)...
  7. pmc Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design
    Ahmed A Khattab
    Cardiology Department, Bern University Hospital, Bern, Switzerland
    Trials 12:56. 2011
    ..The PC-Trial was set up to compare endovascular closure and best medical treatment for prevention of recurrent events...
  8. doi request reprint Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    Stephan Windecker
    Department of Cardiology, and CTU Bern, Bern University Hospital, Bern, Switzerland
    Lancet 372:1163-73. 2008
    ..We compared the safety and efficacy of a biolimus-eluting stent (with biodegradable polymer) with a sirolimus-eluting stent (with durable polymer)...
  9. ncbi request reprint Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock
    Stephan Windecker
    Department of Cardiology, University Hospital Bern, Switzerland
    Curr Opin Crit Care 13:521-7. 2007
    ..This review will discuss the rationale and clinical utility of percutaneous left ventricular assist devices in the management of patients with cardiogenic shock...
  10. ncbi request reprint [Cryptogenic stroke and patent foramen ovale]
    S Windecker
    Inselspital Bern, Universitatsspital, Bern
    Ther Umsch 60:553-61. 2003
    ..Currently, randomised clinical studies compare medical treatment with closure of patent foramen ovale to determine the most effective treatment strategy in this patient population...
  11. doi request reprint Safety of drug-eluting stents
    Stephan Windecker
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Nat Clin Pract Cardiovasc Med 5:316-28. 2008
    ..The purpose of the present Review is to provide the reader with an overview of the benefits and risks of first-generation DESs that could help physicians select the most appropriate stent type for each patient...
  12. ncbi request reprint Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial
    Stephan Windecker
    Invasive Cardiology, Department of Cardiology, University Hospital Bern, Switzerland
    Circulation 111:2617-22. 2005
    ..We designed a prospective, randomized, clinical study to investigate the safety and efficacy of titanium-nitride-oxide-coated stents compared with stainless steel stents...
  13. ncbi request reprint Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke
    Stephan Windecker
    Department of Cardiology, University Hospital, Bern, Switzerland
    J Am Coll Cardiol 44:750-8. 2004
    ..The purpose of this study was to compare the efficacy of medical treatment with percutaneous closure of patent foramen ovale (PFO)...
  14. ncbi request reprint Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
    Stephan Windecker
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    N Engl J Med 353:653-62. 2005
    ..Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between the two types of drug-eluting stents...
  15. ncbi request reprint Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease
    T Pohl
    Division of Cardiology, Swiss Cardiovascular Center of Bern, University Hospital, Bern, Switzerland
    J Am Coll Cardiol 38:1872-8. 2001
    ....
  16. ncbi request reprint Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study
    C Seiler
    Swiss Cardiovascular Center Bern, Cardiology, University Hospital, Bern, Switzerland
    Circulation 104:2012-7. 2001
    ..Experimentally, activated macrophages have been documented to induce vascular proliferation...
  17. ncbi request reprint Sympathetic stimulation using the cold pressor test increases coronary collateral flow
    S F de Marchi
    Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Swiss Med Wkly 131:351-6. 2001
    ..The collateral-flow-increasing effect of CPT is comparable to the recruitment effect of the occlusion itself. This may reflect a coronary collateral vasodilation mediated by the sympathetic nervous system...
  18. ncbi request reprint Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks
    M Schwerzmann
    Department of Cardiology, University Hospital, Bern, Switzerland
    Neurology 62:1399-401. 2004
    ..2 +/- 0.7 vs 0.4 +/- 0.4 per month; p = 0.006). PFO closure did not have an effect on headache frequency in patients with nonmigraine headaches (1.4 +/- 0.9 vs 1.0 +/- 0.9 per month; p = NS)...
  19. ncbi request reprint Percutaneous closure of patent foramen ovale in symptomatic patients
    A Wahl
    Swiss Cardiovascular Center Bern, University Hospital, CH-3010 Bern, Switzerland
    J Interv Cardiol 14:203-9. 2001
    ..The procedure appears a promising therapeutic modality for secondary prevention of recurrent embolism in patients with PFO. Randomized trials must define its therapeutic value...
  20. ncbi request reprint Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism
    A Wahl
    Department of Cardiology, University Hospital Bern, Switzerland
    Neurology 57:1330-2. 2001
    ..3; 95% CI 1.3 to 21.0; p = 0.02). Randomized trials comparing medical treatment with percutaneous PFO closure in the prevention of recurrent embolism are in progress...
  21. pmc Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials
    C Stettler
    Department of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Heart 92:650-7. 2006
    ..To examine whether polymer based coronary stents eluting sirolimus or paclitaxel are equally effective in patients with and without diabetes...
  22. ncbi request reprint Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996
    W Maier
    Cardiology, Swiss Cardiovascular Bern, Bern, Switzerland
    Eur Heart J 22:1733-40. 2001
    ..CONCLUSIONS: An overall increase in PTCAs at an annual rate between 15 and 25% was observed. The wide variation in the use of PTCA in Europe appears to be dependent mostly on economic factors and national health care policies...
  23. ncbi request reprint Prevalence and size of directly detected patent foramen ovale in migraine with aura
    M Schwerzmann
    Department of Cardiology, University Hospital, Inselspital, CH 3010 Bern, Switzerland
    Neurology 65:1415-8. 2005
    ..The anatomy and size of these right-to-left shunts have never been directly assessed...
  24. ncbi request reprint Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism
    A Wahl
    Cardiology Department, University Hospital Bern, Switzerland
    Heart 94:336-41. 2008
    ..To carry out long-term follow-up after percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke...
  25. ncbi request reprint [Non-surgical closure of patent ductus arteriosus: acute and long-term results]
    T Chatterjee
    Kardiologie, Universitatsspital, Bern
    Schweiz Med Wochenschr 130:664-70. 2000
    ..5% per year) and the potential development of congestive heart failure or pulmonary hypertension...
  26. ncbi request reprint Update on transcatheter aortic valve implantation registries and studies
    L Buellesfeld
    Department of Cardiology and Clinical Trials Unit, Bern University Hospital, Bern, Switzerland
    Minerva Cardioangiol 59:419-30. 2011
    ....
  27. ncbi request reprint Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia
    S Windecker
    Cardiology, Swiss Cardiovascular Center Bern, University Hospital Bern, Switzerland
    Circulation 104:928-33. 2001
    ....
  28. doi request reprint Revascularisation of coronary artery disease in patients with diabetes mellitus
    S Cook
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Swiss Med Wkly 139:654-64. 2009
    ..The optimal revascularisation strategy (coronary artery bypass graft surgery versus percutaneous coronary intervention) in diabetic patients with coronary artery disease depends on clinical and anatomical considerations...
  29. pmc Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy
    M Schwerzmann
    Cardiology, Swiss Cardiovascular Centre Bern, University Hospital Inselspital, Bern, Switzerland
    Heart 90:186-90. 2004
    ..To compare the safety and efficacy of percutaneous closure of patent foramen ovale (PFO) with the Amplatzer PFO occluder (Amplatzer) or the PFO STAR device (STAR) in patients with presumed paradoxical embolism...
  30. pmc Outcome of patients with cryptogenic stroke and patent foramen ovale
    K Nedeltchev
    Department of Neurology, Inselspital, University of Bern, 3010 Bern, Switzerland
    J Neurol Neurosurg Psychiatry 72:347-50. 2002
    ..The aim was to estimate the recurrence rate and to define subgroups at increased risk for recurrent cerebral ischaemia in patients with patent foramen ovale (PFO) and so called cryptogenic stroke due to paradoxical embolism...
  31. ncbi request reprint Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale
    P A Berdat
    Swiss Cardiovascular Center Bern and the Division of Pediatric Cardiology, University Hospital, Bern, Switzerland
    J Thorac Cardiovasc Surg 120:1034-9. 2000
    ..However, this procedure may be unsuccessful or complicated and requires surgical treatment...
  32. ncbi request reprint Novel management strategy for patients with suspected pulmonary embolism
    N Kucher
    Cardiology, Swiss Cardiovascular Center, University Hospital, CH 3010, Bern, Switzerland
    Eur Heart J 24:366-76. 2003
    ..A simple management strategy is required for patients with acute pulmonary embolism which allows a rapid and reliable diagnosis in order to start timely and appropriate treatment...
  33. ncbi request reprint The European Registry of Cardiac Catheter Interventions 1997
    W Maier
    University Hospital, Zurich, Switzerland
    Eur Heart J 23:1903-7. 2002
  34. ncbi request reprint Patent foramen ovale: pathophysiology and therapeutic options in symptomatic patients
    A Wahl
    Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland
    Minerva Cardioangiol 49:403-11. 2001
    ..The present article discusses the pathophysiology of the PFO, and the advantages and drawbacks of the different therapeutic options available for symptomatic patients...
  35. ncbi request reprint Drug-eluting stents: limitations of early generation and progress with newer generation devices
    A A Khattab
    Department of Cardiology, Bern University Hospital, Bern, Switzerland
    Minerva Med 101:9-23. 2010
    ..This review will discuss limitations of early generation drug-eluting stents, focus on solutions provided by newer generation devices, and shed light on unresolved issues and potential future solutions...
  36. pmc Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy
    R Zbinden
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Heart 91:1289-93. 2005
    ..To determine the influence of diabetes mellitus on coronary collateral flow by accurate means of collateral flow measurement in a large population with variable degrees of coronary artery disease...
  37. ncbi request reprint Combined percutaneous pulmonary valvuloplasty and atrial septal defect closure for pulmonary valvular stenosis and associated secundum atrial septal defect in an adult
    A Wahl
    Cardiology, Swiss Cardiovascular Center Bern, Bern, Switzerland
    Catheter Cardiovasc Interv 53:68-70. 2001
    ..We report a case of combined percutaneous pulmonary valvuloplasty and secundum atrial septal defect occlusion in an adult patient...
  38. ncbi request reprint Drug-eluting stent thrombosis
    T Pilgrim
    Department of Cardiology, Bern University Hospital, Bern, Switzerland
    Minerva Cardioangiol 57:611-20. 2009
    ..Newer generation DES attempt to address these concerns by aiming at improved vascular healing while maintaining potent neointimal suppression...
  39. doi request reprint Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial
    Lorenz Räber
    Department of Cardiology, Bern University Hospital, 3010 Bern, Switzerland
    Circulation 123:2819-28, 6 p following 2828. 2011
    ....
  40. ncbi request reprint Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions
    Stephane Cook
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Curr Cardiol Rep 11:369-76. 2009
    ..Specifically, we discuss the use of left ventricular assist devices in patients with cardiogenic shock, in patients with acute ST-elevation myocardial infarction without shock, and during high-risk percutaneous coronary interventions...
  41. doi request reprint Atrial fibrillation following device closure of patent foramen ovale
    Annika Burow
    Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Cardiology 111:47-50. 2008
    ..Another cause could be atrial fibrillation (AF). The aim of this study was to determine the incidence of AF in stroke patients after PFO closure...
  42. ncbi request reprint Percutaneous ventricular assist devices for cardiogenic shock
    Stephane Cook
    Curr Heart Fail Rep 5:163-9. 2008
    ..This article reviews available evidence supporting the use of percutaneous ventricular assist devices in patients suffering from cardiogenic shock...
  43. doi request reprint The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications
    Vincent E Friedewald
    Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, TX, USA
    Am J Cardiol 102:32-9. 2008
  44. doi request reprint Images in cardiovascular medicine. Swiss cheese-like atrial septal defect
    Markus Schwerzmann
    Adult Congenital Heart Disease Program, Swiss Cardiovascular Center Bern, University Hospital Inselspital, Freiburgstrasse, 3010 Bern, Switzerland
    Circulation 117:e490-2. 2008
  45. ncbi request reprint Exercise-induced human coronary collateral function: quantitative assessment during acute coronary occlusions
    Tilmann Pohl
    Swiss Cardiovascular Center Bern, University Hospital, CH 3010 Bern, Switzerland
    Cardiology 100:53-60. 2003
    ..0001); start: 0.18 +/- 0.12 vs. 0.22 +/- 0.13, respectively (p = 0.01); end of occlusion: 0.21 +/- 0.14 vs. 0.25 +/- 0.14, respectively (p = 0.007)...
  46. doi request reprint Intra-arterial thrombolysis of acute iatrogenic intracranial arterial occlusion attributable to neuroendovascular procedures or coronary angiography
    Marcel Arnold
    Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
    Stroke 39:1491-5. 2008
    ..However, knowledge of safety and efficacy of IAT in patients with acute stroke as a complication of arterial catheter interventions is limited...
  47. doi request reprint Device-less patent foramen ovale closure by radiofrequency thermal energy
    Nazan B Walpoth
    Cardiovascular Department, University Hospital Bern, Bern, Switzerland
    Swiss Med Wkly 138:108-13. 2008
    ..The goal of this study was to assess the feasibility, safety and success of a system which uses radiofrequency energy (RFE) rather than a device for percutaneous closure of patent foramen ovale (PFO)...
  48. doi request reprint Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients
    Michael Billinger
    Department of Cardiology, University Hospital Bern, 3010 Bern, Switzerland
    Eur Heart J 29:718-25. 2008
    ..We assessed the impact of diabetes on long-term outcome after PCI with sirolimus-eluting (SES) and paclitaxel-eluting (PES) stents...
  49. ncbi request reprint Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation
    Bernhard Meier
    Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Catheter Cardiovasc Interv 60:417-22. 2003
    ....
  50. ncbi request reprint Is alcohol ablation of the septum associated with recurrent tachyarrhythmias?
    Sven Streit
    Swiss Cardiovascular Center, University Hospital, Inselspital, Berne, Switzerland
    Swiss Med Wkly 137:660-8. 2007
    ..It was feared that iatrogenic myocardial infarction due to AA may induce re-entry tachyarrhythmias and increase sudden cardiac death...
  51. ncbi request reprint Late coronary stent thrombosis
    Stephan Windecker
    Cardiovascular Department, University Hospital Bern, 3010 Bern, Switzerland
    Circulation 116:1952-65. 2007
  52. ncbi request reprint A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease
    Albert Schomig
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    J Am Coll Cardiol 50:1373-80. 2007
    ..Our purpose was to make a synthesis of the available evidence on the relative efficacy and safety of 2 drug-eluting stents (DES)--sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES)--in patients with coronary artery disease...
  53. pmc Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis
    Christoph Stettler
    Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland
    BMJ 337:a1331. 2008
    ..To compare the effectiveness and safety of three types of stents (sirolimus eluting, paclitaxel eluting, and bare metal) in people with and without diabetes mellitus...
  54. ncbi request reprint Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?
    Kerstin Wustmann
    Department of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Circulation 107:2213-20. 2003
    ..Such preformed coronary collateral vessels could form the basis for subsequently developing protective natural bypasses in the presence of coronary artery disease...
  55. ncbi request reprint Novel femoral artery puncture closure device in patients undergoing interventional and diagnostic cardiac procedures
    Haresh Mehta
    Swiss Cardiovascular Center Bern, University Hospital, 3010 Bern, Switzerland
    J Invasive Cardiol 14:9-12. 2002
    ..The wide range of closure devices for arterial access sites still leaves room for improvement...
  56. ncbi request reprint Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplasty
    Ali Reza Garachemani
    Swiss Cardiovascular Center, University Hospital, Bern, Switzerland
    Catheter Cardiovasc Interv 55:315-20. 2002
    ..The occurrence of acute ischemic complications was also comparable in the two groups...
  57. ncbi request reprint Effect of endurance training on coronary artery size and function in healthy men: an invasive followup study
    Stephan Windecker
    Department of Cardiology, University Hospital, CH 3010 Bern, Switzerland
    Am J Physiol Heart Circ Physiol 282:H2216-23. 2002
    ..8 +/- 0.8 to 4.5 +/- 0.7 (P = 0.001). Left coronary artery correlated significantly with ventricular mass and maximum oxygen uptake, and coronary flow velocity reserve was significantly associated with maximum workload...
  58. ncbi request reprint Exercise-induced coronary artery vasodilation is not impaired by stent placement
    Willibald Maier
    Department of Cardiology, Swiss Cardiovascular Center, Bern, Switzerland
    Circulation 105:2373-7. 2002
    ..Thus, the purpose of the present study was to determine the vasomotion of stented coronary arteries and to assess its influence on the vasomotion of adjacent vessel segments during bicycle exercise...
  59. ncbi request reprint First clinical results with a new mechanical connector for distal coronary artery anastomoses in CABG
    Friedrich S Eckstein
    Clinic for Cardiovascular Surgery, University Hospital, Bern, Switzerland
    Circulation 106:I1-4. 2002
    ..The initial experience with the first successful creation of mechanical vein-to-coronary artery anastomoses in humans is reported...
  60. ncbi request reprint Two generations of the St. Jude Medical ATG coronary connector systems for coronary artery anastomoses in coronary artery bypass grafting
    Friedrich S Eckstein
    Clinic for Cardiovascular Surgery and Department of Cardiology, University Hospital, Bern, Switzerland
    Ann Thorac Surg 74:S1363-7. 2002
    ..Jude Medical ATG coronary connector systems (investigational stainless steel device, not yet commercially available) for vein-to-coronary artery anastomoses is reported here...
  61. ncbi request reprint Five French versus 6 French PCI: a case control study of efficacy, safety and outcome
    Roby D Rakhit
    Swiss Cardiovascular Center, University Hospital, 3010 Bern, Switzerland
    J Invasive Cardiol 14:670-4. 2002
    ..006). We conclude that the use of 5 Fr guiding catheters is effective and safe in unselected patients undergoing PCI and may even confer certain advantages. The 5 Fr approach can be recommended for routine interventional practice...
  62. ncbi request reprint Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease
    Michael Billinger
    Division of Cardiology, Swiss Cardiovascular Center Bern, CH 3010 Bern, Switzerland
    J Am Coll Cardiol 40:1545-50. 2002
    ..We sought to evaluate whether coronary collateral flow is clinically relevant for future cardiac ischemic events...
  63. ncbi request reprint Four French catheters for diagnostic coronary angiography
    Haresh Mehta
    Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Catheter Cardiovasc Interv 58:275-80. 2003
    ..With increasing use and finesse of these catheters, the difficulty in maneuverability are likely to be overcome...
  64. ncbi request reprint Sirolimus eluting stent: a new era in interventional cardiology?
    Stephan Windecker
    Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Curr Pharm Des 9:1077-94. 2003
    ..In addition, sirolimus eluting stents hold great promise to effectively prevent restenosis...
  65. ncbi request reprint Sirolimus-eluting coronary stents in small vessels
    Bernhard Meier
    Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
    Am Heart J 151:1019.e1-7. 2006
    ..75 mm, length range > or = 15 to < or = 30 mm) 8 months after the implantation of a sirolimus-eluting stent with that of similar vessels with the same drug-eluting stent or a bare stent of the SIRIUS study (historical controls)...
  66. ncbi request reprint Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
    Peter Wenaweser
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Catheter Cardiovasc Interv 70:485-90. 2007
    ..To investigate the outcome of primary percutaneous coronary interventions (PCI) in elderly patients (>/=>/=75 years) with ST-elevation myocardial infarction (STEMI)...
  67. ncbi request reprint Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
    Christoph Stettler
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Lancet 370:937-48. 2007
    ..Our aim was to compare the safety and effectiveness of these stents...
  68. ncbi request reprint Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial
    Mario Togni
    Department of Cardiology, University Hospital Bern, Switzerland
    J Am Coll Cardiol 50:1123-31. 2007
    ....
  69. ncbi request reprint Local vascular dysfunction after coronary paclitaxel-eluting stent implantation
    Mario Togni
    Swiss Cardiovascular Center, University Hospital, CH 3010 Bern, Switzerland
    Int J Cardiol 120:212-20. 2007
    ..However, long-term effects of paclitaxel on vascular function are unknown. The purpose of the present study was to assess coronary vasomotor response to exercise after paclitaxel-eluting stent implantation...
  70. ncbi request reprint Coronary collateral function long after drug-eluting stent implantation
    Pascal Meier
    Department of Cardiology, University Hospital, Bern, Switzerland
    J Am Coll Cardiol 49:15-20. 2007
    ..This study was designed to compare coronary collateral function in patients after bare-metal stent (BMS) or drug-eluting stent (DES) implantation...
  71. ncbi request reprint Polymer stent coating for prevention of neointimal hyperplasia
    Michael Billinger
    Department of Cardiology, University Hospital Bern, Switzerland
    J Invasive Cardiol 18:423-6; discussion 427. 2006
    ..The purpose of the present study was to investigate the effect of poly(L-lysine)-graft-poly(ethyleneglycol) (PLL-g-PEG) adsorbed to stent surfaces to reduce neointimal hyperplasia in the porcine restenosis model...
  72. ncbi request reprint Deleterious effect of coronary brachytherapy on vasomotor response to exercise
    Mario Togni
    Swiss Cardiovascular Center, Inselspital, Bern, Switzerland
    Circulation 110:135-40. 2004
    ..The purpose of the present study was to determine the vasomotor response after brachytherapy and to assess its influence on vasomotion during exercise...
  73. ncbi request reprint Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale
    Markus Schwerzmann
    Swiss Cardiovascular Center Bern, Cardiology, University Hospital, Bern, Switzerland
    Catheter Cardiovasc Interv 63:490-5. 2004
    ..Therefore, implantation of a second closure device in patients with persistence of more than a residual shunt after percutaneous PFO closure appears safe and effective...
  74. ncbi request reprint Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment
    Rolf Vogel
    Department of Cardiology, University Hospital Bern, CH 3010 Bern, Switzerland
    Eur Heart J 27:157-65. 2006
    ..The aims of this human study are (i) to test whether measurements of collateral-derived MBF by MCE are feasible during elective angioplasty and (ii) to validate the concept of pressure-derived collateral-flow assessment...
  75. ncbi request reprint Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology
    Heinrich P Mattle
    Neurology 63:2198-9; author reply 2198-9. 2004
  76. ncbi request reprint Reciprocal relationship between left ventricular filling pressure and the recruitable human coronary collateral circulation
    Stefano F de Marchi
    Cardiology, Swiss Cardiovascular Center Bern, University Hospital, CH 3010 Bern, Switzerland
    Eur Heart J 26:558-66. 2005
    ....
  77. ncbi request reprint Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients
    Andreas Wahl
    Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, CH 3010 Bern, Switzerland
    J Am Coll Cardiol 45:377-80. 2005
    ..This study sought to investigate the safety and efficacy of transcatheter treatment of atrial septal aneurysm (ASA) associated with patent foramen ovale (PFO)...
  78. ncbi request reprint Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction
    Mario Togni
    Swiss Cardiovascular Center Bern, Bern, Switzerland
    J Am Coll Cardiol 46:231-6. 2005
    ..The purpose of the present study was to assess coronary vasomotor response to exercise after sirolimus-eluting stent (SES) implantation...
  79. ncbi request reprint Stent thrombosis is associated with an impaired response to antiplatelet therapy
    Peter Wenaweser
    Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern, Switzerland
    J Am Coll Cardiol 45:1748-52. 2005
    ..We sought to evaluate the response to antiplatelet therapy in patients with stent thrombosis (ST)...
  80. ncbi request reprint Does the beta-blocker nebivolol increase coronary flow reserve?
    Mario Togni
    Swiss Cardiovascular Center Bern, Inselspital, CH 3010 Bern, Switzerland
    Cardiovasc Drugs Ther 21:99-108. 2007
    ..It is unknown, whether coronary perfusion is improved by the increase in NO availability. Therefore, we sought to evaluate the effect of nebivolol on coronary flow reserve (CFR) and collateral flow...
  81. pmc Very late restenosis of a sirolimus-eluting stent after left main coronary artery stenting
    Stephane Cook
    Department of Cardiology, University Hospital Bern, Switzerland
    Can J Cardiol 23:64. 2007
  82. ncbi request reprint Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis
    Peter Wenaweser
    Department of Cardiology, University Hospital, Bern, Switzerland
    Am J Cardiol 99:353-6. 2007
    ..In conclusion, drug-drug interaction between dual antiplatelet therapy and atorvastatin or pravastatin seems not to be associated with ST...
  83. ncbi request reprint Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol
    Michael Billinger
    Cardiology, Swiss Cardiovascular Centre, University Hospital, Bern, Switzerland
    Eur Heart J 25:565-70. 2004
    ..The use of ultrathin Doppler angioplasty guidewires has made it possible to measure collateral flow quantitatively. Pharmacologic interventions have been shown to influence collateral flow and, thus, to affect myocardial ischaemia...
  84. ncbi request reprint Anatomic repair of a left main coronary artery aneurysm
    Friedrich S Eckstein
    Clinic for Cardiovascular Surgery, University Hospital Berne, Freiburgstrasse, CH 3010 Berne, Switzerland
    Eur J Cardiothorac Surg 32:661. 2007
  85. ncbi request reprint Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements
    Pascal Meier
    Department of Cardiology, University Hospital, CH 3010 Bern, Switzerland
    Circulation 116:975-83. 2007
    ..The goal of this study was to assess the impact on survival of quantitatively obtained, recruitable coronary collateral flow in patients with stable coronary artery disease during 10 years of follow-up...
  86. ncbi request reprint Clinical and angiographic results after mechanical connection for distal anastomosis in coronary surgery
    Thierry Carrel
    Clinic for Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland
    J Thorac Cardiovasc Surg 127:1632-40. 2004
    ..We investigated the stainless steel clip system of St Jude Medical/Anastomotic Technology Group (Maple Grove, Minn) to connect saphenous vein grafts with coronary arteries...
  87. ncbi request reprint Clinical relevance of coronary angiography at the time of percutaneous closure of a patent foramen ovale
    Andreas Wahl
    Cardiology, University Hospital Bern, Switzerland
    Catheter Cardiovasc Interv 70:641-5. 2007
    ..The value of incidental coronary angiography during percutaneous shunt closure to screen for asymptomatic coronary artery disease (CAD) is unknown...
  88. ncbi request reprint Thrombosis and drug-eluting stents: an objective appraisal
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55955, USA
    J Am Coll Cardiol 50:109-18. 2007
    ....
  89. ncbi request reprint Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation
    Stephane Cook
    Department of Cardiology, University Hospital Bern, 3010 Bern, Switzerland
    Circulation 115:2426-34. 2007
    ..The present study investigated differences of the stented segment between patients with and without very late stent thrombosis with the use of intravascular ultrasound...
  90. ncbi request reprint Clinical end points in coronary stent trials: a case for standardized definitions
    Donald E Cutlip
    Harvard Clinical Research Institute, Harvard Medical School, 930 Commonwealth Avenue, Boston, MA 02215, USA
    Circulation 115:2344-51. 2007
    ..Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of assessment have created confusion in interpretation...
  91. ncbi request reprint Coronary collateral flow in response to endurance exercise training
    Rainer Zbinden
    Department of Cardiology, University Hospital, Bern, Switzerland
    Eur J Cardiovasc Prev Rehabil 14:250-7. 2007
    ....
  92. ncbi request reprint Transseptal TandemHeart implantation through an Amplatzer atrial septal occluder
    Stephane Cook
    Invasive Cardiology Department, Swiss Cardiovascular Center Bern, Bern, Switzerland
    J Invasive Cardiol 19:198-9. 2007
  93. ncbi request reprint Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
    Joost Daemen
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands
    Lancet 369:667-78. 2007
    ..Stent thrombosis is a safety concern associated with use of drug-eluting stents. Little is known about occurrence of stent thrombosis more than 1 year after implantation of such stents...
  94. ncbi request reprint Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome
    Peter Wenaweser
    Department of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, 3010 Bern, Switzerland
    Eur Heart J 26:1180-7. 2005
    ..To investigate the efficacy and outcome of emergency percutaneous coronary interventions (PCI) in patients with stent thrombosis...